Chargement en cours...
The benefits of statin therapy—what questions remain?
Early hydroxymethylglutaryl‐CoA reductase inhibitor (statin) trials provided the first evidence of the benefits of statin therapy in secondary prevention of coronary heart disease (CHD). Outcomes data from more recent trials involving atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastat...
Enregistré dans:
| Publié dans: | Clin Cardiol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley Periodicals, Inc.
2006
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654705/ https://ncbi.nlm.nih.gov/pubmed/16450792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960281103 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|